Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPRT1 | P00492 | 14/20 | 1.00 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.45 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.44 |
| ▸ | TYMP | P19971 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | VCP | P55072 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9189461 | 0.91 | HPRT1 (1.00) | HPRT1FGFR1SLC22A6TYMP | |
| SCHEMBL9055682 | 0.90 | HPRT1 (0.81) | HPRT1FGFR1SLC22A6TYMPMEN1 | |
| SCHEMBL4713155 | 0.86 | HPRT1 (0.76) | HPRT1TYMPCYP3A4 | |
| SCHEMBL28646181 | 0.86 | HPRT1 (0.75) | HPRT1MEN1ALDH1A1LMNACYP3A4 | |
| SCHEMBL9417241 | 0.85 | HPRT1 (0.74) | HPRT1FGFR1SLC22A6TYMPMEN1 | |
| SCHEMBL8896070 | 0.85 | HPRT1 (0.74) | HPRT1FGFR1SLC22A6MEN1ALDH1A1 | |
| Phosphoric Acid SCHEMBL15054256 | 0.85 | HPRT1 (0.74) | HPRT1TYMPCYP3A4 | |
| SCHEMBL28513633 | 0.84 | HPRT1 (0.72) | HPRT1MEN1ALDH1A1LMNACYP3A4 | |
| SCHEMBL9054484 | 0.83 | HPRT1 (0.71) | HPRT1 | |
| SCHEMBL8752240 | 0.83 | HPRT1 (0.71) | HPRT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 127 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6964968-B2 | Method for the treatment or prevention of viral infection using nucleoside analogues | SHIRE BIOCHEM, INC. (CA) | 2005-11-15 | — | — | US | claimed |
| US-6583149-B1 | 2-hydroxymethyl-4-(cytosin-1'-yl)-1,3-Dioxolane | BIOCHEM PHARMA INC. (CA) | 2003-06-24 | — | — | US | claimed |
| US-12403291-B2 | Submucosal bioresorbable drug eluting platform | INTERSECT ENT, INC. (US) | 2025-09-02 | — | — | US | disclosed |
| US-20240269350-A1 | IMPLANTABLE MATRIX FOR TREATING CENTRAL NERVOUS SYSTEM DISORDERS | LYRA THERAPEUTICS, INC. | 2024-08-15 | — | — | US | disclosed |
| US-20230389690-A1 | PERSONAL CLEANSING WAND | Silicon Valley Innovations, Inc. | 2023-12-07 | — | — | US | disclosed |
| EP-4225168-A1 | PERSONAL CLEANSING WAND | Silicon Valley Innovations, Inc. (US) | 2023-08-16 | — | — | EP | disclosed |
| EP-4221645-A1 | OSMOTIC DRUG DELIVERY IMPLANTS | Lyra Therapeutics, Inc. (US) | 2023-08-09 | — | — | EP | disclosed |
| US-20230233451-A1 | OSMOTIC DRUG DELIVERY IMPLANTS | LYRA THERAPEUTICS, INC. | 2023-07-27 | — | — | US | disclosed |
| US-11684146-B2 | Personal cleansing wand | Silicon Valley Innovations, Inc. (US) | 2023-06-27 | — | — | US | disclosed |
| US-11672959-B2 | Expandable member systems and methods for drug delivery | INTERSECT ENT, INC. (US) | 2023-06-13 | — | — | US | disclosed |
| US-11654216-B2 | Self-expanding devices and methods therefor | INTERSECT ENT, INC. (US) | 2023-05-23 | — | — | US | disclosed |
| EP-0897917-A1 | Compounds for use in the preparation of antiretroviral enantiomeric nucleotide analogs | INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY OF THE ACADEMY OF SCIENCES OF THE CZECH REPUBLIC (CZ) | 1999-02-24 | — | — | EP | disclosed |
| US-5854228-A | Antiviral phosphonomethoxyalkylene purine and pyrimidine derivatives | INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY OF THE ACADEMY OF SCIENCES OF THE CZECH REPUBLIC (CZ) | 1998-12-29 | — | — | US | disclosed |
| US-5650510-A | VIRICIDES OR ANTITUMOR AGENTS | INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY OF THE ACADEMY OF SCIENCES OF THE CZECH REPUBLIC (CZ) | 1997-07-22 | — | — | US | disclosed |
| EP-0452935-B1 | Chiral 2-(phosphonomethoxy)propyl guanines as antiviral agents | ACAD OF SCIENCE CZECH REPUBLIC (CS) | 1995-06-21 | — | — | EP | disclosed |
| EP-0654037-A1 | ANTIRETROVIRAL ENANTIOMERIC NUCLEOTIDE ANALOGS | INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY OF THE ACADEMY OF SCIENCES OF THE CZECH REPUBLIC (CZ) | 1995-05-24 | — | — | EP | disclosed |
| US-5302585-A | Viricides, HIV virus | INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY OF THE ACADEMY OF SCIENCES OF THE CZECH REPUBLIC (CS) | 1994-04-12 | — | — | US | disclosed |
| WO-1994003467-A2 | ANTIRETROVIRAL ENANTIOMERIC NUCLEOTIDE ANALOGS | INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY OF THE ACADEMY OF SCIENCES OF THE CZECH REPUBLIC (CZ) | 1994-02-17 | — | — | WO | disclosed |
| EP-0452935-A1 | Chiral 2-(phosphonomethoxy)propyl guanines as antiviral agents | INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY OF THE ACADEMY OF SCIENCES OF THE CZECH REPUBLIC (CS) | 1991-10-23 | — | — | EP | disclosed |
| EP-0269947-A1 | Antiviral phosphonomethoxyalkylene purine and pyrimidine derivatives | INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY OF THE ACADEMY OF SCIENCES OF THE CZECH REPUBLIC (CS) | 1988-06-08 | — | — | EP | disclosed |